DANIELS RONALD J

Director at MOORE WALLACE INC · on record since Oct 28, 2003
Director at BridgeBio Pharma, Inc. · on record since Feb 14, 2020

Insider trading activity of DANIELS RONALD J

Transactions on record: 21; since Oct 28, 2003

Open-market buys: 2; $298.7K

Open-market sells: 2; $4M

Companies traded: 2; last filing Jun 24, 2026

Figures computed from official regulatory filings — .

Companies where DANIELS RONALD J has traded

BridgeBio Pharma, Inc.15 tx · $6.5M · Jun 24, 2026
MOORE WALLACE INC6 tx · $9.8K · Mar 2, 2004

Track record of DANIELS RONALD J

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of DANIELS RONALD J

Co-insiders of DANIELS RONALD J

Abell Keith WMOORE WALLACE INC
AGUIAR ERICBridgeBio Pharma, Inc.
ANGELSON MARK AMOORE WALLACE INC
Apuli MaricelBridgeBio Pharma, Inc.
Cook Jennifer E.BridgeBio Pharma, Inc.
CUMMINGS ROBERT F JRMOORE WALLACE INC
Dachille Douglas A.BridgeBio Pharma, Inc.
ECKERT ALFRED C IIIMOORE WALLACE INC
Ellis AndreaBridgeBio Pharma, Inc.
GREENWICH STREET INVESTMENTS II LLCMOORE WALLACE INC
GSCP NJ INCMOORE WALLACE INC
GSCP NJ L PMOORE WALLACE INC
HALVORSEN OLE ANDREASBridgeBio Pharma, Inc.
HAMWEE ROBERTMOORE WALLACE INC
HASSAN FREDBridgeBio Pharma, Inc.
HAYDEN RICHARD MMOORE WALLACE INC
HENDERSON MICHAEL THOMASBridgeBio Pharma, Inc.
HILTWEIN MARK SMOORE WALLACE INC
HOMCY CHARLES JBridgeBio Pharma, Inc.
INGLESBY THOMAS VMOORE WALLACE INC
KAUFMAN MATTHEWMOORE WALLACE INC
KKR & Co. L.P.BridgeBio Pharma, Inc.
KKR Fund Holdings L.P.BridgeBio Pharma, Inc.
KKR Genetic Disorder GP LLCBridgeBio Pharma, Inc.
KKR Genetic Disorder L.P.BridgeBio Pharma, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2026	Award	3,990	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2026	AwardD (derivative)	5,277	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Nov 7, 2025	Sell	-61,031	63.72 USD	$3.9M		SEC
BridgeBio Pharma, Inc.Listing on record	Nov 7, 2025	ExerciseD (derivative)	-61,031	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Nov 7, 2025	Exercise	61,031	34.65 USD	$2.1M		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2025	Award	6,589	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2025	AwardD (derivative)	8,425	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 25, 2024	AwardD (derivative)	26,014	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 23, 2023	AwardD (derivative)	51,501	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2022	AwardD (derivative)	104,921	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Dec 30, 2021	Buy	10,402	14.34 USD	$149.2K	conv 65Cluster	SEC
BridgeBio Pharma, Inc.Listing on record	Dec 30, 2021	Sell	-11,745	12.80 USD	$150.3K		SEC
BridgeBio Pharma, Inc.Listing on record	Dec 30, 2021	Buy	11,745	12.73 USD	$149.5K	conv 79First in 12mo	SEC
BridgeBio Pharma, Inc.Listing on record	Jun 22, 2021	AwardD (derivative)	38,895	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Feb 14, 2020	AwardD (derivative)	91,554	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MOORE WALLACE INCListing unverified	Mar 2, 2004	OtherD (derivative)	-5,000	—	n/a (No price was disclosed in the filing)		SEC
MOORE WALLACE INCListing unverified	Mar 2, 2004	OtherD (derivative)	-3,877	—	n/a (No price was disclosed in the filing)		SEC
MOORE WALLACE INCListing unverified	Mar 2, 2004	OtherD (derivative)	-3,750	—	n/a (No price was disclosed in the filing)		SEC
MOORE WALLACE INCListing unverified	Mar 2, 2004	Other	-3,525	—	n/a (No price was disclosed in the filing)		SEC
MOORE WALLACE INCListing unverified	Jan 5, 2004	AwardD (derivative)	199.68	—	n/a (No price was disclosed in the filing)		SEC
MOORE WALLACE INCListing unverified	Oct 28, 2003	AwardD (derivative)	570.78	17.20 USD	$9.8K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2026	Award	3,990	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2026	AwardD (derivative)	5,277	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Nov 7, 2025	Sell	-61,031	63.72 USD	$3.9M		SEC
BridgeBio Pharma, Inc.Listing on record	Nov 7, 2025	ExerciseD (derivative)	-61,031	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Nov 7, 2025	Exercise	61,031	34.65 USD	$2.1M		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2025	Award	6,589	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2025	AwardD (derivative)	8,425	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 25, 2024	AwardD (derivative)	26,014	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 23, 2023	AwardD (derivative)	51,501	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2022	AwardD (derivative)	104,921	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Dec 30, 2021	Buy	10,402	14.34 USD	$149.2K	conv 65Cluster	SEC
BridgeBio Pharma, Inc.Listing on record	Dec 30, 2021	Sell	-11,745	12.80 USD	$150.3K		SEC
BridgeBio Pharma, Inc.Listing on record	Dec 30, 2021	Buy	11,745	12.73 USD	$149.5K	conv 79First in 12mo	SEC
BridgeBio Pharma, Inc.Listing on record	Jun 22, 2021	AwardD (derivative)	38,895	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Feb 14, 2020	AwardD (derivative)	91,554	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MOORE WALLACE INCListing unverified	Mar 2, 2004	OtherD (derivative)	-5,000	—	n/a (No price was disclosed in the filing)		SEC
MOORE WALLACE INCListing unverified	Mar 2, 2004	OtherD (derivative)	-3,877	—	n/a (No price was disclosed in the filing)		SEC
MOORE WALLACE INCListing unverified	Mar 2, 2004	OtherD (derivative)	-3,750	—	n/a (No price was disclosed in the filing)		SEC
MOORE WALLACE INCListing unverified	Mar 2, 2004	Other	-3,525	—	n/a (No price was disclosed in the filing)		SEC
MOORE WALLACE INCListing unverified	Jan 5, 2004	AwardD (derivative)	199.68	—	n/a (No price was disclosed in the filing)		SEC
MOORE WALLACE INCListing unverified	Oct 28, 2003	AwardD (derivative)	570.78	17.20 USD	$9.8K		SEC